Abercynon, Wales – November 28th, 2024. Imspex Diagnostics is pleased to announce its successful application for a SMART Flexible Innovation Support (SMART FIS) grant, awarded by the Welsh Government in support of the Company’s innovative research and development initiatives. This recognition underscores Imspex’s commitment to advancing use of cutting-edge analytical instruments and devices that deliver digitally transmitted actionable data in real-time to patients and clinical practitioners.
The grant will enable Imspex to focus on increasing its product development pipeline and driving impactful innovation across critical disease pathways. This marks another milestone in the Company’s journey to deliver advanced solutions that address real-world challenges in healthcare.
John McKinley, CEO of Imspex Diagnostics, commented:
“We are thrilled to receive this support, which reflects the confidence in our vision of transforming healthcare harnessing the potential of digital solutions and advanced technologies that offer not only faster accurate diagnosis, but the opportunity to predict exacerbations for patients and supporting health services. It will further empower our team to push the boundaries of innovation and deliver meaningful advancements in our diagnostics field.”
Imspex Diagnostics remains committed to creating innovative solutions that redefine industry standards and improve outcomes for our healthcare partners and patients. The Company looks forward to sharing more details about the exciting developments this funding will support in the coming months.
About Imspex Diagnostics
Imspex Diagnostics specializes in the development of advanced analytical technologies, with a focus on delivering impactful solutions for healthcare, environmental monitoring and applied industry markets.
Media Contact
Amber Jacobs
PR & Marketing Manager, Imspex Diagnostics
Email: amber@imspex.com
Phone: +44 (0)7920051743